atezolizumab
roche
['kare', 'atezo']
#cedarssinaicancer at #aacr23. dr. karen reckamp is co-author on the poster efficacy and safety of adjuvant #atezolizumab from the phase 2 lcmc3 study being presented today at 6:00am pt 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.